Blog
RSS FeedPosted by Michael Wonder on 19 Jul 2021
Decision to widen access to rituximab for people with B-cell acute lymphoblastic leukaemia/lymphoma
9 July 2021 - PHARMAC is widening access to rituximab (Riximyo) to include treatment of people with newly diagnosed B-cell ...
Posted by Michael Wonder on 14 Jul 2021
No more sending Kiwis across the ditch as new national neuroendocrine cancer treatment service opens
14 July 2021 - The opening of a new multimillion dollar national service to treat neuroendocrine cancer means patients will ...
Posted by Michael Wonder on 14 Jul 2021
PM speaks about COVID-19, Fiji and PHARMAC funding
14 July 2021 - Prime Minister Jacinda Ardern spoke to media after a speech at the New Zealand Institute of International ...
Posted by Michael Wonder on 14 Jul 2021
PHARMAC 'cruel' for failing to fund drugs for rare illnesses — advocate
14 July 2021 - New Zealand’s drug-buying agency doesn’t value the lives of all people equally, according to those advocating for ...
Posted by Michael Wonder on 14 Jul 2021
PHARMAC has for decades refused to fund Synagis drug that could save vulnerable babies from RSV
14 July 2021 - Newshub can reveal after two decades of refusing to fund a drug that could halve the ...
Posted by Michael Wonder on 07 Jul 2021
Access to miracle drug Trikafta a 'lifeline' for cystic fibrosis patients with no other hope
7 July 2021 - A handful of cystic fibrosis patients have been thrown a lifeline with a drug company offering ...
Posted by Michael Wonder on 01 Jul 2021
PHARMAC is seeking views on declining funding applications
29 June 2021 - PHARMAC is considering declining 97 inactive medicine funding applications. ...
Posted by Michael Wonder on 30 Jun 2021
New Zealand Pharmaceutical Schedule - 1 July 2021 update
1 July 2021 - The July 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Jun 2021
Nurse prescribers now able to initiate Special Authority medicines
30 June 2021 - Joint media release with the Ministry of Health ...
Posted by Michael Wonder on 22 Jun 2021
Nib launches new product providing greater access to unfunded medicines
23 June 2021 - nib New Zealand has launched a new health insurance add-on which provides Kiwis with access to ...
Posted by Michael Wonder on 22 Jun 2021
Proposal for the supply of primidone and gabapentin
22 June 2021 - PHARMAC is seeking additional feedback on a proposal to change the funded brands of primidone tablets ...
Posted by Michael Wonder on 21 Jun 2021
Medsafe approves Pfizer vaccine for New Zealand 12-15 year olds
21 June 2021 - Prime Minister Jacinda Ardern has welcomed Medsafe's "very carefully considered" provisional approval of the Pfizer/BioNTech vaccine ...
Posted by Michael Wonder on 15 Jun 2021
Uptake of medicines for type 2 diabetes mellitus
15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...
Posted by Michael Wonder on 11 Jun 2021
PHARMAC’s decision over diabetes drugs could see up to 140,000 ‘miss out’, doctor says
11 June 2021 - Dr John Baker, the chair of the Diabetes Foundation Aotearoa, says that has to change and highlights ...
Posted by Michael Wonder on 09 Jun 2021
Stop blaming PHARMAC - we'd be worse off without it
10 June 2021 - Penny Tucker is concerned that there are “miracle drugs and biologics that have transformed many conditions ...